πŸ‡ΊπŸ‡Έ FDA
Patent

US 11667687

Masked activatable interferon constructs

granted A61KA61K38/00A61P

Quick answer

US patent 11667687 (Masked activatable interferon constructs) held by CytomX Therapeutics, Inc. expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CytomX Therapeutics, Inc.
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/00, A61P, A61P35/00